Quote:
Originally Posted by SupDock
It did?
*****
In conclusion, the clinical, virological, and pathological findings presented in this study revealed no exacerbation of infection in the rhesus macaques immunized with the inactivated SARS-CoV Z-1 vaccine following challenge with SARS-CoV NS-1. Therefore, these results preliminarily indicated that low levels of antibodies induced by the inactivated SARS-CoV Z-1 vaccine may not induce ADE in rhesus
macaques, and the vaccine could be a good candidate for clinical trials.
https://link.springer.com/article/10...250-018-0009-2
******
Read more here
https://www.medpagetoday.com/special...clusives/91648
You continue to throw things against the wall and hope something sticks. I keep telling myself I will quit responding. |
There are thousands upon thousands of doctors and scientists voicing concerns about these things, including the inventor of mRNA technology, yet you act as if it's just me.
At this early stage in clinical trials, what makes you so confident in its safety? What makes you think that all of their concerns are invalid?
Remember, I'm the one who is just saying there are factors that might deserve more consideration. You're the ones who are adamant that the risks are low.